Dr. Dalman has served as a faculty member of Stanford Surgery since 1992, and directed the Vascular Surgery program from 2005 to 2021. He currently holds the Chidester Professorship in the Department of Surgery. His clinical interests include management of aortic diseases and lower extremity circulatory disorders, including limb salvage. He is a member of the Vascular Surgery Board, American Board of Surgery, and a past member of the Residency Review Committee for Surgery, ACGME. At Stanford Health Care he serves as Co-Director for the Cardiovascular Service Line. At the School of Medicine, Dr. Dalman is a Steering Committee and founding member of the Cardiovascular Institute (CVI). Prior to his appointment as Chief of Vascular Surgery at Stanford Health Care, Dalman served as Chief of Vascular Surgery at the Veterans Affairs Palo Alto Health Care System for 14 years. Dr. Dalman's research laboratory studies the pathophysiology of abdominal aortic aneurysm (AAA) disease, a leading cause of death in developed and developing countries worldwide, and is actively engaged in identifying and validating new treatment measures for AAA. Dr. Dalman's laboratory has received continuous research funding from the National Institutes of Health since 1999, and collaborates with leading investigators in AAA disease worldwide.